AMLN (DIABETES DRUGS) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : AMLN (DIABETES DRUGS)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: MulhollandDrive who wrote (1005)	12/12/1997 2:37:00 AM
From: D.Right	Read Replies (1) of 2173

Hello everyone: It is painful to watch the falling prices of many of the biotech companies. But, don't lose your sight when things are tough, the market cap of AMLN is now approaching a level that is close to the total cash JNJ HAS PAID for the half right of pramlintide. They could have bought the whole company with that much money now. JNJ should know as well as anybody the potential of pramlintide. WS does whatever it has to do, however, a chance to buy AMLN at this level in this late stage of its drug development is an opportunity in a life time. A Christmas gift only WS is capable of giving. Good luck to everyone. D.Right

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next